These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24503204)

  • 41. Instrumentally assessed gait quality is more relevant than gait endurance and velocity to explain patient-reported walking ability in early-stage multiple sclerosis.
    Carpinella I; Gervasoni E; Anastasi D; Di Giovanni R; Tacchino A; Brichetto G; Confalonieri P; Rovaris M; Solaro C; Ferrarin M; Cattaneo D
    Eur J Neurol; 2021 Jul; 28(7):2259-2268. PubMed ID: 33864413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Walking-Related Motor Fatigue in Persons With Multiple Sclerosis: Decline in Walking Distance Induced by the 6-Minute Walk Test.
    Leone C; Severijns D; Doležalová V; Baert I; Dalgas U; Romberg A; Bethoux F; Gebara B; Santoyo Medina C; Maamâgi H; Rasova K; Maertens de Noordhout B; Knuts K; Skjerbaek A; Jensen E; Wagner JM; Feys P
    Neurorehabil Neural Repair; 2016 May; 30(4):373-83. PubMed ID: 26216790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construct Validity of the Four Square Step Test in Multiple Sclerosis.
    Kalron A; Givon U
    Arch Phys Med Rehabil; 2016 Sep; 97(9):1496-1501. PubMed ID: 27181182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.
    Applebee A; Goodman AD; Mayadev AS; Bethoux F; Goldman MD; Klingler M; Blight AR; Carrazana EJ
    Clin Ther; 2015 Dec; 37(12):2780-7. PubMed ID: 26565077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining a supervised and home-based task-oriented circuit training improves walking endurance in patients with multiple sclerosis. The MS_TOCT randomized-controlled trial.
    Straudi S; De Marco G; Martinuzzi C; Baroni A; Lamberti N; Brondi L; Da Roit M; Pizzongolo LDM; Basaglia N; Manfredini F
    Mult Scler Relat Disord; 2022 Apr; 60():103721. PubMed ID: 35276451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Group-based, individualized, comprehensive core stability and balance intervention provides immediate and long-term improvements in walking in individuals with multiple sclerosis: A randomized controlled trial.
    Arntzen EC; Straume B; Odeh F; Feys P; Normann B
    Physiother Res Int; 2020 Jan; 25(1):e1798. PubMed ID: 31268223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomised controlled pilot trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the Step it Up study.
    Hayes S; Uszynski MK; Motl RW; Gallagher S; Larkin A; Newell J; Scarrott C; Coote S
    BMJ Open; 2017 Oct; 7(10):e016336. PubMed ID: 29025830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reliability and Concurrent Validity of the Narrow Path Walking Test in Persons With Multiple Sclerosis.
    Rosenblum U; Melzer I
    J Neurol Phys Ther; 2017 Jan; 41(1):43-51. PubMed ID: 27977520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Timed Up-and-Go and 2-Minute Walk Test in patients with multiple sclerosis with mild disability: reliability, responsiveness and link with perceived fatigue.
    Valet M; Lejeune T; Devis M; van Pesch V; El Sankari S; Stoquart G
    Eur J Phys Rehabil Med; 2019 Aug; 55(4):450-455. PubMed ID: 30311490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.
    Mañago MM; Callesen J; Dalgas U; Kittelson J; Schenkman M
    Mult Scler Relat Disord; 2020 Jul; 42():102052. PubMed ID: 32240963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychometric properties of the Croatian version of the Multiple Sclerosis Walking Scale (MSWS-12).
    Jerković A; Nikolić Ivanišević M; Šimić N; Poljičanin A; Đogaš Z; Rogić Vidaković M
    Disabil Rehabil; 2023 Oct; 45(20):3373-3378. PubMed ID: 36222552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine.
    Sola-Valls N; Blanco Y; Sepúlveda M; Llufriu S; Martínez-Lapiscina EH; Zubizarreta I; Pulido-Valdeolivas I; Montejo C; Villoslada P; Saiz A
    Ther Adv Neurol Disord; 2018; 11():1756286418780007. PubMed ID: 29977342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reliability and validity of the 4-meter walk test in patients with multiple sclerosis.
    Ozkan T; Unluer NO; Ates-Sari Y; Hangun SF; Vural G
    Mult Scler Relat Disord; 2024 Jul; 87():105679. PubMed ID: 38759422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Objective and subjective measures of daily physical activity in persons with Multiple Sclerosis beginning a rehabilitation regime: A cross-sectional study.
    Torchio A; Fusari G; Perini G; Crispiatico V; Grosso C; Cattaneo D; Pagliari C; Jonsdottir J
    Mult Scler Relat Disord; 2022 Dec; 68():104394. PubMed ID: 36544306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined training improves walking mobility in persons with significant disability from multiple sclerosis: a pilot study.
    Motl RW; Smith DC; Elliott J; Weikert M; Dlugonski D; Sosnoff JJ
    J Neurol Phys Ther; 2012 Mar; 36(1):32-7. PubMed ID: 22333922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing walking disability in multiple sclerosis.
    Kieseier BC; Pozzilli C
    Mult Scler; 2012 Jul; 18(7):914-24. PubMed ID: 22740603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validity of minimal clinically important difference values for the multiple sclerosis walking scale-12?
    Motl RW; Learmonth YC; Pilutti LA; Dlugonski D; Klaren R
    Eur Neurol; 2014; 71(3-4):196-202. PubMed ID: 24457548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Accelerated Trajectories of Walking Capacity Across the Adult Life Span in Persons With Multiple Sclerosis: An Underrecognized Challenge.
    Hvid LG; Feys P; Baert I; Kalron A; Dalgas U
    Neurorehabil Neural Repair; 2020 Apr; 34(4):360-369. PubMed ID: 32126896
    [No Abstract]   [Full Text] [Related]  

  • 59. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validity and reliability of the 3-meter backward walk test in patients with multiple sclerosis.
    Katirci Kirmaci Zİ; Adiguzel H; Erel S; Neyal AM; Neyal A; Ergun N
    Mult Scler Relat Disord; 2022 Jul; 63():103842. PubMed ID: 35594633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.